Human corneal endothelial cell transplantation using nanocomposite gel sheet in bullous keratopathy.

IF 1.9 Q4 CELL BIOLOGY American journal of stem cells Pub Date : 2018-02-01 eCollection Date: 2018-01-01
Periasamy Parikumar, Kazutoshi Haraguchi, Rajappa Senthilkumar, Samuel Jk Abraham
{"title":"Human corneal endothelial cell transplantation using nanocomposite gel sheet in bullous keratopathy.","authors":"Periasamy Parikumar,&nbsp;Kazutoshi Haraguchi,&nbsp;Rajappa Senthilkumar,&nbsp;Samuel Jk Abraham","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Transplantation of <i>in vitro</i> expanded human corneal endothelial precursors (HCEP) cells using a nanocomposite (D25-NC) gel sheet as supporting material in bovine's cornea has been earlier reported. Herein we report the transplantation of HCEP cells derived from a cadaver donor cornea to three patients using the NC gel sheet. In three patients with bullous keratopathy, one after cataract surgery, one after trauma and another in the corneal graft, earlier performed for congenital corneal dystrophy, not amenable to medical management HCEP cells isolated from a human cadaver donor cornea <i>in vitro</i> expanded using a thermoreversible gelation polymer (TGP) for 26 days were divided into three equal portions and 1.6 × 10<sup>5</sup> HCEP cells were injected on to the endothelium of the affected eye in each patient using the D25-NC gel sheet as a supporting material. The sheets were removed after three days. The bullae in the cornea disappeared by the 3<sup>rd</sup>-11<sup>th</sup> post-operative day in all the three patients. Visual acuity improved from Perception of light (PL)+/Projection of rays (PR)+ to Hand movements (HM)+ in one of the patients by post-operative day 3 which was maintained at 18 months follow-up. At 18 months follow-up, in another patient the visual acuity had improved from HM+ to 6/60 while in the third patient, visual acuity remained HM+ as it was prior to HCEP transplantation. There were no adverse effects during the follow-up in any of the patients.</p>","PeriodicalId":7657,"journal":{"name":"American journal of stem cells","volume":"7 1","pages":"18-24"},"PeriodicalIF":1.9000,"publicationDate":"2018-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5840311/pdf/ajsc0007-0018.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American journal of stem cells","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2018/1/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"CELL BIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Transplantation of in vitro expanded human corneal endothelial precursors (HCEP) cells using a nanocomposite (D25-NC) gel sheet as supporting material in bovine's cornea has been earlier reported. Herein we report the transplantation of HCEP cells derived from a cadaver donor cornea to three patients using the NC gel sheet. In three patients with bullous keratopathy, one after cataract surgery, one after trauma and another in the corneal graft, earlier performed for congenital corneal dystrophy, not amenable to medical management HCEP cells isolated from a human cadaver donor cornea in vitro expanded using a thermoreversible gelation polymer (TGP) for 26 days were divided into three equal portions and 1.6 × 105 HCEP cells were injected on to the endothelium of the affected eye in each patient using the D25-NC gel sheet as a supporting material. The sheets were removed after three days. The bullae in the cornea disappeared by the 3rd-11th post-operative day in all the three patients. Visual acuity improved from Perception of light (PL)+/Projection of rays (PR)+ to Hand movements (HM)+ in one of the patients by post-operative day 3 which was maintained at 18 months follow-up. At 18 months follow-up, in another patient the visual acuity had improved from HM+ to 6/60 while in the third patient, visual acuity remained HM+ as it was prior to HCEP transplantation. There were no adverse effects during the follow-up in any of the patients.

Abstract Image

分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
纳米复合凝胶片移植人角膜内皮细胞治疗大疱性角膜病变。
用纳米复合材料(D25-NC)凝胶片作为支撑材料将体外扩增的人角膜内皮前体细胞(HCEP)移植到牛角膜中已有报道。在此,我们报告了使用NC凝胶片将来自尸体供体角膜的HCEP细胞移植给三名患者。在3例大疱性角膜病变患者中,1例在白内障手术后,1例在外伤后,另1例在角膜移植后,早期因先天性角膜营养不良而进行手术,采用热可逆凝胶化聚合物(TGP)体外扩增26天,从人尸体供体角膜中分离HCEP细胞,将其分成三等份,使用D25-NC凝胶片作为支撑材料,将1.6 × 105个HCEP细胞注射到每位患者受影响眼的内皮细胞上。三天后,床单被移走了。3例患者均于术后第3 ~ 11天角膜大疱消失。其中1例患者术后第3天视力由光感(PL)+/光线投射(PR)+改善至手部运动(HM)+,随访18个月。在18个月的随访中,另一名患者的视力从HM+改善到6/60,而第三名患者的视力保持HM+,与HCEP移植前一样。在随访期间,所有患者均未出现不良反应。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Innovative approaches in neural stem cell therapy: a comprehensive review of mechanisms and applications. Exosome-rich mesenchymal stem cell secretome improves strength in patients with amyotrophic lateral sclerosis, Kennedy disease, congenital myasthenic syndrome and Lewy body dementia. The role of FN1 gene interference in neural differentiation of human bone marrow mesenchymal stem cells. Synergistic growth factors preconditioning strategy to improve hepatic differentiation efficiency of UC-MSCs in vitro. Safety and efficacy of allogeneic umbilical cord-derived mesenchymal stem cell transplantation in type 2 diabetes: a pilot clinical trial.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1